Biomicrofluidics. 2010 Apr 16;4(2):024101. doi: 10.1063/1.3398319.
This work describes the development of a prototypic microfluidic platform for the generation of stepwise concentration gradients of drugs. A sensitive apoptotic analysis method is integrated into this microfluidic system for studying apoptosis of HeLa cells under the influence of anticancer drug, etoposide, with various concentrations in parallel; it measures the yellow fluorescent proteincyan fluorescent protein fluorescence resonance energy transfer (FRET) signal that responds to the activation of caspase-3, an indicator of cell apoptosis. Sets of microfluidic valves on the chip generate stepwise concentration gradient of etoposide in various cell-culture microchambers. The FRET signals from multiple chambers are simultaneously monitored under a fluorescent microscope for long-time observation and the on-chip results are compared with those from 96-well plate study and the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. The microfluidic platform shows several advantages including high-throughput capacity, low drug consumption, and high sensitivity.
这项工作描述了一种用于生成药物逐步浓度梯度的原型微流控平台的开发。一种敏感的细胞凋亡分析方法被整合到这个微流控系统中,用于研究在不同浓度抗癌药物依托泊苷的影响下,宫颈癌 HeLa 细胞的凋亡;它测量了对 caspase-3 激活有反应的黄色荧光蛋白-青色荧光蛋白荧光共振能量转移(FRET)信号,caspase-3 是细胞凋亡的一个指标。芯片上的微流控阀在多个细胞培养微室中产生依托泊苷的逐步浓度梯度。在荧光显微镜下同时监测多个腔室的 FRET 信号,进行长时间观察,并将芯片上的结果与 96 孔板研究和噻唑蓝(MTT)检测法的结果进行比较。该微流控平台具有高通量、低药物消耗和高灵敏度等优点。